Home/ Stocks/ OLMA

Olema Pharmaceuticals, Inc. Common Stock

OLMA XNAS

$12.05 +0.25 (+2.12%) ▲ 15-min delayed

Open

$11.93

High

$12.21

Low

$11.87

Volume

757.2K

Market Cap

$1.03B

About Olema Pharmaceuticals, Inc. Common Stock

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 137 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-53,089,000	$-0.52
FY 2025	$0	$-162,451,000	$-1.87
Q3 2025	$0	$-42,217,000	$-0.49
Q2 2025	$0	$-43,784,000	$-0.51

Related Market News

No specific coverage for OLMA yet. Check out our latest market news or earnings calendar.

Get OLMA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Olema Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.